These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 8930008)

  • 1. Safety of mirtazapine: a review.
    Montgomery SA
    Int Clin Psychopharmacol; 1995 Dec; 10 Suppl 4():37-45. PubMed ID: 8930008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mirtazapine : A Review of its Pharmacology and Therapeutic Potential in the Management of Major Depression.
    Davis R; Wilde MI
    CNS Drugs; 1996 May; 5(5):389-402. PubMed ID: 26071050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mirtazapine versus amitriptyline in the long-term treatment of depression: a double-blind placebo-controlled study.
    Montgomery SA; Reimitz PE; Zivkov M
    Int Clin Psychopharmacol; 1998 Mar; 13(2):63-73. PubMed ID: 9669186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy of mirtazapine: a review of meta-analyses of pooled data.
    Kasper S
    Int Clin Psychopharmacol; 1995 Dec; 10 Suppl 4():25-35. PubMed ID: 8930007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression.
    Fawcett J; Barkin RL
    J Affect Disord; 1998 Dec; 51(3):267-85. PubMed ID: 10333982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of randomized, double-blind, placebo-controlled, efficacy and safety studies of mirtazapine versus amitriptyline in major depression.
    Stahl S; Zivkov M; Reimitz PE; Panagides J; Hoff W
    Acta Psychiatr Scand Suppl; 1997; 391():22-30. PubMed ID: 9265948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mirtazapine: clinical advantages in the treatment of depression.
    Burrows GD; Kremer CM
    J Clin Psychopharmacol; 1997 Apr; 17 Suppl 1():34S-39S. PubMed ID: 9090576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis.
    Watanabe N; Omori IM; Nakagawa A; Cipriani A; Barbui C; McGuire H; Churchill R; Furukawa TA;
    CNS Drugs; 2010 Jan; 24(1):35-53. PubMed ID: 20030418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A risk-benefit assessment of mirtazapine in the treatment of depression.
    Kasper S; Praschak-Rieder N; Tauscher J; Wolf R
    Drug Saf; 1997 Oct; 17(4):251-64. PubMed ID: 9352961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of mirtazapine in overdose.
    Bremner JD; Wingard P; Walshe TA
    J Clin Psychiatry; 1998 May; 59(5):233-5. PubMed ID: 9632033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mirtazapine added to selective serotonin reuptake inhibitors for treatment-resistant depression in primary care (MIR trial): study protocol for a randomised controlled trial.
    Tallon D; Wiles N; Campbell J; Chew-Graham C; Dickens C; Macleod U; Peters TJ; Lewis G; Anderson IM; Gilbody S; Hollingworth W; Davies S; Kessler D
    Trials; 2016 Feb; 17():66. PubMed ID: 26842107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J; Barkin RL
    J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder.
    Smith WT; Glaudin V; Panagides J; Gilvary E
    Psychopharmacol Bull; 1990; 26(2):191-6. PubMed ID: 2236455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mirtazapine: a review of its use in major depression.
    Holm KJ; Markham A
    Drugs; 1999 Apr; 57(4):607-31. PubMed ID: 10235695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerability and patient compliance.
    Roose SP
    J Clin Psychiatry; 1999; 60 Suppl 17():14-7; discussion 46-8. PubMed ID: 10446736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mirtazapine in combination with amitriptyline: a drug-drug interaction study in healthy subjects.
    Sennef C; Timmer CJ; Sitsen JM
    Hum Psychopharmacol; 2003 Mar; 18(2):91-101. PubMed ID: 12590402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.
    Leinonen E; Skarstein J; Behnke K; Agren H; Helsdingen JT
    Int Clin Psychopharmacol; 1999 Nov; 14(6):329-37. PubMed ID: 10565799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.
    Bremner JD
    J Clin Psychiatry; 1995 Nov; 56(11):519-25. PubMed ID: 7592505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the pharmacological and clinical profile of mirtazapine.
    Anttila SA; Leinonen EV
    CNS Drug Rev; 2001; 7(3):249-64. PubMed ID: 11607047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety in overdose of mirtazapine: a case report.
    Gerritsen AW
    J Clin Psychiatry; 1997 Jun; 58(6):271. PubMed ID: 9228894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.